Boone Capital Management »

Amphastar Pharmaceuticals shares owned by Boone Capital Management

Quarter-by-quarter ownership of Amphastar Pharmaceuticals (AMPH) shares owned by Boone Capital Management from 13F filings

Historical chart of Boone Capital Management investment in Amphastar Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals held by Boone Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals by Boone Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $25M 400k 61.85

More positions owned by Boone Capital Management

Unum (UNM)
Colfax Corp (ENOV)
Amgen (AMGN)
CVS Caremark Corporation (CVS)
Globus Med Cl A (GMED)
Cigna Corp (CI)
Danaher Corporation (DHR)
Amphastar Pharmaceuticals (AMPH)
Molina Healthcare (MOH)
Baxter International (BAX)
Viatris (VTRS)
Ideaya Biosciences (IDYA)
Bridgebio Pharma (BBIO)
Berry Plastics (BERY)
Quanterix Ord (QTRX)

View all positions for Boone Capital Management

Top funds holding Amphastar Pharmaceuticals

Federated Investors
Vanguard Group
Neuberger Berman Group
Dimensional Fund Advisors
TD Asset Management
T. Rowe Price Associates
Boone Capital Management
Charles Schwab Investment Management
Oberweis Asset Management
Nordea Investment Management Ab
Bessemer
LSV Asset Management
Bank of New York Mellon
Mesirow Institutional Investment Management
Victory Capital Management

View all funds holding Amphastar Pharmaceuticals